Sunitinib malate and sorafenib may be beneficial at the treatment of advanced bladder cancer due to their anti-angiogenic effects
Mesrur Selcuk Silay, Cengiz MirogluVolume:
69
Year:
2007
Language:
english
DOI:
10.1016/j.mehy.2007.01.065
File:
PDF, 89 KB
english, 2007